Interferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ.

Shinohara, Nobuo

Interferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ. [electronic resource] - Japanese journal of clinical oncology Feb 2012 - 113-9 p. digital

Publication Type: Journal Article

1465-3621

10.1093/jjco/hyr176 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma in Situ--drug therapy
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Cimetidine--administration & dosage
Dexamethasone--administration & dosage
Female
Humans
Immunotherapy--methods
Interferon-alpha--immunology
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Male
Meloxicam
Middle Aged
Neoadjuvant Therapy--methods
Nephrectomy
Thiazines--administration & dosage
Thiazoles--administration & dosage
Treatment Outcome